Characterization of two fructosyl-amino acid oxidase homologs of Schizosaccharomyces pombe

2004 ◽  
Vol 97 (4) ◽  
pp. 278-280 ◽  
Author(s):  
Nobuyuki Yoshida ◽  
Shin-Ichi Akazawa ◽  
Tohoru Katsuragi ◽  
Yoshiki Tani
2010 ◽  
Vol 7 (6) ◽  
pp. 1424-1434 ◽  
Author(s):  
Masumi Katane ◽  
Yasuaki Saitoh ◽  
Yousuke Seida ◽  
Masae Sekine ◽  
Takemitsu Furuchi ◽  
...  

2012 ◽  
Vol 65 (6) ◽  
pp. 764-769 ◽  
Author(s):  
Shouji Takahashi ◽  
Hirotsune Okada ◽  
Katsumasa Abe ◽  
Yoshio Kera

2003 ◽  
Vol 49 (2) ◽  
pp. 269-274 ◽  
Author(s):  
Ikunosuke Sakurabayashi ◽  
Tatsurou Watano ◽  
Satoshi Yonehara ◽  
Kaori Ishimaru ◽  
Kaoru Hirai ◽  
...  

Abstract Background: Previous methods to measure glycohemoglobin (GHb) have been time-consuming or imprecise; we therefore developed a new enzymatic assay for GHb. Methods: Blood cells were first hemolyzed, and hemoglobin was digested with protease to yield fructosyl amino acid. Fructosyl amino acid oxidase acts on the fructosyl amino acid and generates hydrogen peroxide, which reacts with chromogens in the presence of peroxidase. Total hemoglobin was measured spectrometrically in the same reaction tube. The results were reported as the ratio of the concentrations of GHb and hemoglobin. Results: The measured values were comparable to those determined with a HPLC method and with an immunoassay in blood samples from 2854 patients with diabetes. Regression analysis for the enzymatic assay (y) vs the HPLC method (x) produced the following: r = 0.979; slope, 0.994 [95% confidence interval (CI), 0.986–1.001]; y-intercept, 0.04% (95% CI, −0.09% to 0.01%); n = 2854. For the enzymatic assay (y) vs the immunoassay (x), the regression statistics were as follows: r = 0.982; slope, 1.002 (95% CI, 0.995–1.009); y-intercept, 0% (95% CI, −0.05% to 0.05%); n = 2854. Conclusions: The values measured by the new enzymatic assay are sufficiently correlated with those of the conventional HPLC method and immunoassay, but the proposed assay for GHb is rapid and has high precision.


2009 ◽  
Vol 3 (3) ◽  
pp. 585-592 ◽  
Author(s):  
Stefano Ferri ◽  
Seungsu Kim ◽  
Wakako Tsugawa ◽  
Koji Sode

Glycated proteins, particularly glycated hemoglobin A1c, are important markers for assessing the effectiveness of diabetes treatment. Convenient and reproducible assay systems based on the enzyme fructosyl amino acid oxidase (FAOD) have become attractive alternatives to conventional detection methods. We review the available FAOD-based assays for measurement of glycated proteins as well as the recent advances and future direction of FAOD research. Future research is expected to lead to the next generation of convenient, simple, and economical sensors for glycated protein, ideally suited for point-of-care treatment and self-monitoring applications.


Sign in / Sign up

Export Citation Format

Share Document